Online Library: Crohn's Disease
The following pages provide an overview of the most recent research and clinical studies about the health benefits of micronutrients in fighting Crohn's disease. This collection of scientific facts proves that anyone who privately or publicly questions the health value of micronutrients does not serve YOUR health, or the health of the people, but rather the multi-billion dollar investment 'business with disease' based on patented pharmaceutical drugs.
We encourage you to forward the link to this important online library on natural health – one of the largest ones in the world – to your friends. You may also print out the articles you find most important for your own health condition and share them with your doctor. Any responsibly acting health professional will be grateful to receive such science-based health education.
Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent crohn's disease
Source: Inflammatory bowel diseases 2011; 17(10):2116-21
Affiliation: Center for Digestive Disorders, Section of Gastroenterology, Department of Medicine, Boston Medical Center, Boston, Massachusetts
Abstract: Vitamin D deficiency is a common problem in patients with Crohn's disease. Researchers used a novel vitamin D bioavailability test to examine the ability of patients with quiescent Crohn's disease (CD) to absorb vitamin D(2). Study participants were comprised of 37 CD patients (51% female) and 10 control (50% female) with no recent exposure to vitamin D(2). After a baseline blood draw, subjects were given a a single 50,000 IU oral dose of vitamin D(2) in a capsule formulation and had their blood drawn 12 hours later to determine serum vitamin D(2) , which reflected their vitamin D(2) absorption capacity. While both control and CD subjects, on average, experienced a rise in vitamin D levels, the CD patients had on average a 30% decrease in their ability to absorb vitamin D(2) relative to control subjects. There was no statistical difference for Vitamin D(2) absorption in CD patients with regard to location of disease, whether or not they had received surgery, or the type of surgery received. More than 70% of the CD patients were vitamin D deficient or insufficient. This study found that the ability of CD patients to absorb vitamin D(2) is unpredictable. Their ability to absorb vitamin D(2) can be determined by performing a bioavailabilty test which may guide clinicians in administering the appropriate therapeutic dose of vitamin D for treating vitamin D deficiency in patients with CD.